Abstract:
The embodiments described herein are directed to biodegradable stents comprising an inner biodegradable metal scaffold and an outer polymeric coating. The biodegradable coating consists preferentially of biodegradable polymers and may additionally include at least one pharmacologically active substance such as an anti-inflammatory, cytostatic, cytotoxic, antiproliferative, anti-microtubuli, antiangiogenic, antirestenotic (anti-restenosis), antifungicide, antineoplastic, antimigrative, athrombogenic and/or antithrombogenic agent.
Abstract:
Software is disclosed that creates a way of controlling alterations to cell contents of a data flow network so they can easily be turned on and off as separate layers. These layers can then be grouped as scenarios. Scenarios allow different layers of formula changes to be easily added and removed from the model.
Abstract:
The present invention relates to in vitro cultured skin tissue, and in particular to cultured skin tissue comprising exogenous genes encoding angiogenic growth factors. In some embodiments, the keratinocytes express exogenous angiopoietin-1 or a member of the VEGF family, preferably VEGF-A. In particularly preferred embodiments, the keratinocytes are incorporated into cultured skin tissue.
Abstract:
The present invention relates to methods for coating the entire surface of lattice-like or mesh-like endoprostheses, wherein the endoprostheses initially are being provided with a thin layer covering the material surface of the endoprosthesis and subsequently, the surface of the entire endoprosthesis is being coated, wherein said coating of the entire surface covers the struts as well as the interstices between the individual struts.
Abstract:
Software technology is used to build and perform object-oriented financial modeling. A software framework creates highly reusable and layered business objects. Business objects organize financial information and save time through ease of use and a simple intuitive interface.
Abstract:
Software is disclosed that creates a way of controlling alterations to cell contents of a data flow network so they can easily be turned on and off as separate layers. These layers can then be grouped as scenarios. Scenarios allow different layers of formula changes to be easily added and removed from the model.
Abstract:
The present invention relates to in vitro cultured skin substitutes, and in particular to in vitro cultured skin substitutes that have improved barrier function. In some embodiments, improved barrier function is a result of improved culture conditions, while in other embodiments, improved barrier function results from genetic modification of keratinocytes. Improved culture conditions to improve barrier function include organotypic culture in the presence of linoleic acid and/or linoleic acid at about 75% humidity. Suitable genetic modifications for improving barrier function includes transfection with a DNA construct capable of expressing GKLF.
Abstract:
A position transducer device is provided for detecting the position of a position transmitter. The position transducer device comprises a housing extending in a longitudinal direction and a measuring sensor arranged in the housing and extending parallel to the longitudinal direction. The position transmitter is coupled to the measuring sensor in a non-contacting manner. The outer surface of the housing is designed such that it can be enclosed at least partially by a fixing receiving means for fixing the housing to an application. The housing can be rotated relative to the position transmitter in the fixing receiving means in order to enable adjustment of the distance between the measuring sensor and the position transducer.
Abstract:
In order to provide a position transducer device for detecting the position of a position transmitter, comprising a housing extending in a longitudinal direction and a measuring sensor arranged in the housing and extending parallel to the longitudinal direction, the position transmitter being coupled to this measuring sensor without contact, which is variable in its use for a user it is suggested that an outer surface of the housing be designed such that it can be enclosed at least partially by a fixing receiving means for fixing it to an application and that the housing can be rotated in the fixing receiving means.
Abstract:
The invention relates to stents with at least one hemocompatible coating which contains an antiproliferative, antiinflammatory and/or antithrombotic active agent, methods for the preparation of said stents as well as the use of said stents for the prevention of restenosis.